Article de revue
Achieving high uptake of human papillomavirus vaccine in Cameroon: Lessons learned in overcoming challenges
With adequate education of all stakeholders, HPV vaccination is acceptable and feasible in Cameroon. Following this demonstration project, in 2014 the Global Access to Vaccines and Immunization (GAVI) Alliance awarded the Cameroon MOH HPV vaccine at a price of US$4.50 per dose to immunize sixth grade girls and girls aged 10 years who are not in school in two districts of Cameroon.
Auteurs
Langues
- Anglais
Année de publication
2014
Journal
Vaccine
Volume
35
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Papillomavirus humain
Pays
- Cameroun
Organisations
- Gavi, l'Alliance du vaccin
Mots-clés
- Introduction de nouveaux vaccins
- Suivi de performance
- Planification, budgétisation et financement
Régions de l'OMS
- Région africaine